Cell ID, a Singapore-based med-tech company, has announced that its portable genetic Quiz PCR Biochip test can be conducted via saliva specimen or nasal swab to detect the SARS-CoV-2 virus within minutes. The company also claims that it is commercially ready and can be used via an app on a laptop to conduct tests anytime, anywhere.
Empower has entered into a North American Re-Seller and Distribution Agreement with API Pharma for its rapid antigen test and rapid antibody test, for which it has submitted a request for Emergency Use Authorisation (EUA) to the US food and Drug Administration (FDA).
LGC has submitted a request for EUA to the FDA for its high-throughput RT-PCR testing system to detect the SARS-CoV-2 virus. LGC’s high-throughput RT-PCR workflow can deliver approximately 35,000 tests per day with just one scaling system.
The Wyss Institute for Biologically Inspired Engineering at Harvard University has licensed its eRapid technology to The iQ Group Global for Covid-19 diagnostic applications. The Australian consortium intends to integrate the technology with its transistor technology for specific and sensitive SARS-CoV-2 testing to address gaps in the development of Covid-19 diagnostics.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData